However, SARS-CoV-2-specific CD4+ T cells were detected in only 77% of acute COVID-19 samples (23/30) (Figure 2C), with similar observations for individual peptide pools (S, M, N, and MP_R; Figures 2A and 2B). This evidence concerns the gene CD4 and COVID-19.